{
  "recommendations": [
    "Consider CT Pulmonary Angiography (CTPA) for acute chest pain and shortness of breath, given the high clinical suspicion for pulmonary embolism.",
    "Given the patient's severe CKD (Stage 4, eGFR 22.0) and hypotension (MAP 57.0 mmHg), carefully weigh the risks and benefits of intravenous contrast administration for CTPA.",
    "If CTPA is pursued, ensure adequate hydration and consider a reduced contrast volume or an alternative non-contrast imaging strategy if feasible and diagnostically adequate.",
    "If the primary concern is not pulmonary embolism but rather to assess for other cardiopulmonary etiologies, a non-contrast chest CT (such as Low-Dose CT Chest) might be a safer alternative in the context of severe renal impairment."
  ],
  "rationale": [
    "Patient presents with acute symptoms (shortness of breath, chest pain) concerning for pulmonary embolism, a primary indication for CTPA.",
    "Severe CKD (Stage 4, eGFR 22.0) and hypotension (MAP 57.0 mmHg) significantly increase the risk of contrast-induced nephropathy (CIN) and hemodynamic instability with contrast administration.",
    "KDIGO and ACR guidelines emphasize caution with contrast in patients with compromised renal function and hemodynamic instability.",
    "The option of a non-contrast study is highlighted as a safer alternative given the patient's renal status, aligning with ACR recommendations."
  ],
  "protocol_selection": [
    {
      "protocol_id": "CT_CHEST_ANGIO_PULMONARY_EMBOLISM",
      "name": "CT Pulmonary Angiography (Chest CTA for PE)",
      "indications": [
        "pulmonary embolism",
        "acute chest pain",
        "shortness of breath"
      ],
      "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism.",
      "contrast_timing": "Pulmonary arterial phase: ∼6–13 sec post-injection.",
      "contrast_dose": "Weight-based; ~100–150 mL iodinated contrast (300 mg I/mL); follow ACR Manual.",
      "renal_safety_notes": "Ensure contrast-to-eGFR ratio <1.1 g/(mL/min); if eGFR <30, consider non-contrast alternatives or weigh risks carefully.",
      "references": [
        "Contrast CT phases overview (Wikipedia):contentReference[oaicite:0]{index=0}",
        "CT pulmonary angiogram practical notes (Wikipedia):contentReference[oaicite:1]{index=1}"
      ]
    },
    {
      "protocol_id": "CT_CHEST_LOW_DOSE_SCREENING",
      "name": "Low-Dose CT Chest — Lung Cancer Screening",
      "indications": [
        "lung cancer screening",
        "high-risk cohorts"
      ],
      "description": "Low-dose CT of lungs targeting <3 mGy radiation dose while maintaining image quality.",
      "contrast_timing": "N/A — non-contrast low-dose protocol.",
      "contrast_dose": "None.",
      "renal_safety_notes": "Ideal in patients with renal dysfunction due to non-use of contrast.",
      "references": [
        "Low-dose CT screening dose benchmarks PMC:contentReference[oaicite:6]{index=6}"
      ]
    }
  ]
}